|
Acceptable Intake N-Nitrosobiotin (N-Nitrosamide)
|
|
2
|
180
|
January 13, 2025
|
|
Development of a Simultaneous Analytical Method for Amines Corresponding to 10 Typical Nitrosamines
|
|
0
|
487
|
December 30, 2024
|
|
N-nitrosoamides - a horse of a different color
|
|
47
|
5367
|
December 18, 2024
|
|
Formation of Nitroso-Omeprazole
|
|
5
|
1756
|
December 12, 2024
|
|
Autonomous CPCA Web-based calculator FREE
|
|
31
|
5380
|
December 12, 2024
|
|
What is CPCA Score for “N-nitroso of 3-Amino-1,2,4-triazole"
|
|
5
|
227
|
October 30, 2024
|
|
Hexamethyldisilazane (HMDS) can form Nitrosamine Impurity?
|
|
7
|
504
|
October 29, 2024
|
|
Primeros pasos para evaluar nitrosaminas en medicamentos
|
|
5
|
183
|
September 23, 2024
|
|
N-Nitroso Carbidopa
|
|
2
|
280
|
September 12, 2024
|
|
Can API with amide should considered a potential candidate for forming nitrosamine impurity
|
|
5
|
293
|
September 12, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
22
|
1628
|
September 5, 2024
|
|
N-nitroso-rivaroxaban amide
|
|
6
|
1431
|
August 29, 2024
|
|
How much Amine and Nitrating agent "Stoichiometric Ratio" required for formation of Nitrosamine impurities?
|
|
3
|
199
|
August 28, 2024
|
|
Health Canada: Nitrosamine impurities Update July 26, 2024
|
|
14
|
1132
|
August 26, 2024
|
|
DMF in API, specification limit in formulation
|
|
5
|
721
|
August 26, 2024
|
|
Nitrosamine impurities of related substances of API's
|
|
7
|
803
|
August 12, 2024
|
|
N-nitroso Omeprazole
|
|
4
|
1389
|
August 3, 2024
|
|
Control limit of Nitrosamines and N-nitroso compounds
|
|
2
|
421
|
July 8, 2024
|
|
Non-mutagenic, carcinogenic impurities
|
|
3
|
496
|
June 30, 2024
|
|
MEGLUMINE (Methylglucamine)
|
|
18
|
2587
|
June 19, 2024
|
|
Tetrazole nitrosamines
|
|
1
|
276
|
June 13, 2024
|
|
Update: EFPIA workflows for Quality Risk management Jun 2024 v03
|
|
2
|
761
|
June 4, 2024
|
|
AI limit of API having very law MDD
|
|
1
|
324
|
May 27, 2024
|
|
Category 5 NDSRIs- CPCA tool
|
|
2
|
483
|
May 20, 2024
|
|
Nitrosamine in Azathioprine
|
|
4
|
846
|
May 14, 2024
|
|
APIC NA Risk Assessment Template
|
|
5
|
3287
|
May 11, 2024
|
|
Risk Analysis for Ergotamine Tartrate
|
|
4
|
419
|
April 22, 2024
|
|
Nitrosamines: A new systematic review
|
|
8
|
3088
|
April 13, 2024
|
|
AI Limit for Nitroso Nebivolol
|
|
11
|
2687
|
April 3, 2024
|
|
AI difference between FDA and EMA, HC and TGA
|
|
0
|
1091
|
March 22, 2024
|